好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Nonconvulsive Status Epilepticus: Value of a Benzodiazepine Trial for Predicting Outcomes
Epilepsy/Clinical Neurophysiology (EEG)
(-)
006
Authors/Disclosures
Alan Krumholz, MD, FAAN (University of Maryland Medical School) No disclosure on file
Jennifer L. Hopp, MD, FAAN (University of Maryland Medical System) Dr. Hopp has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for GOODELL, DEVRIES, LEECH & DANN, LLP. The institution of Dr. Hopp has received research support from MII TA Grant 20180828 TEDCO EpiWatch: A Mobile Health Application for Epilepsy Management. The institution of Dr. Hopp has received research support from MII TA Grant TEDCO Project #0723-012 EPIScalp; A Novel Tool for Diagnosing Epilepsy from Scalp EEG. Dr. Hopp has received publishing royalties from a publication relating to health care. Dr. Hopp has received personal compensation in the range of $5,000-$9,999 for serving as a Faculty with J. Kiffin Penry Epilepsy 好色先生al Programs.
No disclosure on file
Elizabeth Barry, MD No disclosure on file
George J. Hart, MD (Bryn Mawr Medical Specialist Association) No disclosure on file
R E. Faught, Jr., MD, FAAN (Emory University) Dr. Faught has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Azurity. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gideon, Essary, Tardio and Carter PLC, Nashville TN TN law firm. Dr. Faught has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Friedman Dazio and Zulanas Law Firm Birmingham AL. The institution of Dr. Faught has received research support from UCB Pharma.